Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Pharmacovigilance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview 2022-2027:

The global pharmacovigilance market size reached US$ 6.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2027, exhibiting a CAGR of 10.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Pharmacovigilance (PV) is the pharmacological science concerning the detection, assessment, understanding and prevention of unfavorable effects with pharmaceutical products. It plays a pivotal role in identifying previously unknown adverse effects, recognizing changes in the frequency or severity, and assessing the risks and benefits of drugs to determine required actions. It also ensures the accuracy of communicated information to healthcare professionals and patients. At present, PV is widely used to understand the effects of drugs on individuals worldwide.

Pharmacovigilance Market Trends:

The increasing prevalence of lifestyle diseases, such as hypertension, diabetes, and cardiac disorders, has resulted in the rising consumption of drugs worldwide. This, in confluence with the growing incidences of adverse drug reactions (ADRs), represents one of the key factors driving the global pharmacovigilance market. Besides this, the key players are introducing advanced platforms to ensure automated ADR reporting, which is contributing to the market growth. They are also focusing on improving the manufacturing operations and streamlining research and development (R&D) on account of a competitive environment. Furthermore, leading pharmaceutical companies are undertaking numerous initiatives to conduct clinical trials and generate awareness about the proper utilization of medicines. This, in turn, is facilitating the growth of the pharmacovigilance market. Additionally, the coronavirus disease (COVID-19) outbreak has resulted in the urgent need for a vaccine, which has created numerous opportunities for the market players. Apart from this, pharmaceutical manufacturers are shifting towards outsourcing pharmacovigilance operations to third parties on account of the associated benefits, such as increasing internal resource flexibility and better outcomes over shorter periods. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmacovigilance market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on service provider, product life cycle, type, process flow, therapeutic area and end use.

Breakup by Service Provider:

  • In-house
  • Contract Outsourcing
     

Breakup by Product Life Cycle:

  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
     

Breakup by Type:

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining
     

Breakup by Process Flow:

  • Case Data Management
    • Case Logging
    • Case Data Analysis
    • Medical Reviewing and Reporting
  • Signal Detection
    • Adverse Event Logging
    • Adverse Event Analysis
    • Adverse Event Review and Reporting
  • Risk Management System
    • Risk Evaluation System
    • Risk Mitigation System
       

Breakup by Therapeutic Area:

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory Systems
  • Others
     

Breakup by End Use:

  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture plc, ArisGlobal LLC, BioClinica Inc. (Cinven Partners LLP), Capgemini, Cognizant, International Business Machines Corporation, ICON plc., IQVIA Inc., ITClinical, Parexel International Corporation and Wipro Limited.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Service Provider, Product Life Cycle, Type, Process Flow, Therapeutic Area, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Accenture plc, ArisGlobal LLC, BioClinica Inc. (Cinven Partners LLP), Capgemini, Cognizant, International Business Machines Corporation, ICON plc., IQVIA Inc., ITClinical, Parexel International Corporation and Wipro Limited
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global pharmacovigilance market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmacovigilance market?
  • What are the key regional markets?
  • What is the breakup of the market based on the service provider?
  • What is the breakup of the market based on the product life cycle?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the process flow?
  • What is the breakup of the market based on the therapeutic area?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmacovigilance market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Pharmacovigilance Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Service Provider
    6.1    In-house
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Contract Outsourcing
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Product Life Cycle
    7.1    Pre-clinical
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Phase I
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Phase II
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Phase III
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Phase IV
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Type
    8.1    Spontaneous Reporting
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Intensified ADR Reporting
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Targeted Spontaneous Reporting
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Cohort Event Monitoring
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    EHR Mining
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by Process Flow
    9.1    Case Data Management
        9.1.1 Market Trends
        9.1.2 Major Types
           9.1.2.1 Case Logging
           9.1.2.2 Case Data Analysis
           9.1.2.3 Medical Reviewing and Reporting
        9.1.3 Market Forecast
    9.2    Signal Detection
        9.2.1 Market Trends
        9.2.2 Major Types
           9.2.2.1 Adverse Event Logging
           9.2.2.2 Adverse Event Analysis
           9.2.2.3 Adverse Event Review and Reporting
        9.2.3 Market Forecast
    9.3    Risk Management System
        9.3.1 Market Trends
        9.3.2 Major Types
           9.3.2.1 Risk Evaluation System
           9.3.2.2 Risk Mitigation System
        9.3.3 Market Forecast
10  Market Breakup by Therapeutic Area
    10.1    Oncology
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Neurology
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Cardiology
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Respiratory Systems
        10.4.1 Market Trends
        10.4.2 Market Forecast
    10.5    Others
        10.5.1 Market Trends
        10.5.2 Market Forecast
11  Market Breakup by End Use
    11.1    Pharmaceuticals Companies
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2    Biotechnology Companies
        11.2.1 Market Trends
        11.2.2 Market Forecast
    11.3    Medical Device Companies
        11.3.1 Market Trends
        11.3.2 Market Forecast
    11.4    Others
        11.4.1 Market Trends
        11.4.2 Market Forecast
12  Market Breakup by Region
    12.1    North America
        12.1.1 United States
           12.1.1.1 Market Trends
           12.1.1.2 Market Forecast
        12.1.2 Canada
           12.1.2.1 Market Trends
           12.1.2.2 Market Forecast
    12.2    Asia-Pacific
        12.2.1 China
           12.2.1.1 Market Trends
           12.2.1.2 Market Forecast
        12.2.2 Japan
           12.2.2.1 Market Trends
           12.2.2.2 Market Forecast
        12.2.3 India
           12.2.3.1 Market Trends
           12.2.3.2 Market Forecast
        12.2.4 South Korea
           12.2.4.1 Market Trends
           12.2.4.2 Market Forecast
        12.2.5 Australia
           12.2.5.1 Market Trends
           12.2.5.2 Market Forecast
        12.2.6 Indonesia
           12.2.6.1 Market Trends
           12.2.6.2 Market Forecast
        12.2.7 Others
           12.2.7.1 Market Trends
           12.2.7.2 Market Forecast
    12.3    Europe
        12.3.1 Germany
           12.3.1.1 Market Trends
           12.3.1.2 Market Forecast
        12.3.2 France
           12.3.2.1 Market Trends
           12.3.2.2 Market Forecast
        12.3.3 United Kingdom
           12.3.3.1 Market Trends
           12.3.3.2 Market Forecast
        12.3.4 Italy
           12.3.4.1 Market Trends
           12.3.4.2 Market Forecast
        12.3.5 Spain
           12.3.5.1 Market Trends
           12.3.5.2 Market Forecast
        12.3.6 Russia
           12.3.6.1 Market Trends
           12.3.6.2 Market Forecast
        12.3.7 Others
           12.3.7.1 Market Trends
           12.3.7.2 Market Forecast
    12.4    Latin America
        12.4.1 Brazil
           12.4.1.1 Market Trends
           12.4.1.2 Market Forecast
        12.4.2 Mexico
           12.4.2.1 Market Trends
           12.4.2.2 Market Forecast
        12.4.3 Others
           12.4.3.1 Market Trends
           12.4.3.2 Market Forecast
    12.5    Middle East and Africa
        12.5.1 Market Trends
        12.5.2 Market Breakup by Country
        12.5.3 Market Forecast
13  SWOT Analysis
    13.1    Overview
    13.2    Strengths
    13.3    Weaknesses
    13.4    Opportunities
    13.5    Threats
14  Value Chain Analysis
15  Porters Five Forces Analysis

    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16  Price Analysis
17  Competitive Landscape

    17.1    Market Structure
    17.2    Key Players
    17.3    Profiles of Key Players
        17.3.1    Accenture plc
           17.3.1.1 Company Overview
           17.3.1.2 Product Portfolio
           17.3.1.3 Financials
           17.3.1.4 SWOT Analysis
        17.3.2    ArisGlobal LLC
           17.3.2.1 Company Overview
           17.3.2.2 Product Portfolio
        17.3.3    BioClinica Inc. (Cinven Partners LLP)
           17.3.3.1 Company Overview
           17.3.3.2 Product Portfolio
           17.3.3.3 SWOT Analysis
        17.3.4    Capgemini
           17.3.4.1 Company Overview
           17.3.4.2 Product Portfolio
        17.3.5    Cognizant
           17.3.5.1 Company Overview
           17.3.5.2 Product Portfolio
           17.3.5.3 Financials
           17.3.5.4 SWOT Analysis
        17.3.6    International Business Machines Corporation
           17.3.6.1 Company Overview
           17.3.6.2 Product Portfolio
           17.3.6.3 Financials
           17.3.6.4 SWOT Analysis
        17.3.7    ICON plc.
           17.3.7.1 Company Overview
           17.3.7.2 Product Portfolio
           17.3.7.3 Financials
           17.3.7.4 SWOT Analysis
        17.3.8    IQVIA Inc.
           17.3.8.1 Company Overview
           17.3.8.2 Product Portfolio
           17.3.8.3 Financials
           17.3.8.4 SWOT Analysis
        17.3.9    ITClinical
           17.3.9.1 Company Overview
           17.3.9.2 Product Portfolio
        17.3.10    Parexel International Corporation
           17.3.10.1 Company Overview
           17.3.10.2 Product Portfolio
           17.3.10.3 SWOT Analysis
        17.3.11    Wipro Limited
           17.3.11.1 Company Overview
           17.3.11.2 Product Portfolio
           17.3.11.3 Financials
           17.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Pharmacovigilance Market: Major Drivers and Challenges
Figure 2: Global: Pharmacovigilance Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Pharmacovigilance Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Pharmacovigilance Market: Breakup by Service Provider (in %), 2021
Figure 5: Global: Pharmacovigilance Market: Breakup by Product Life Cycle (in %), 2021
Figure 6: Global: Pharmacovigilance Market: Breakup by Type (in %), 2021
Figure 7: Global: Pharmacovigilance Market: Breakup by Process Flow (in %), 2021
Figure 8: Global: Pharmacovigilance Market: Breakup by Therapeutic Area (in %), 2021
Figure 9: Global: Pharmacovigilance Market: Breakup by End Use (in %), 2021
Figure 10: Global: Pharmacovigilance Market: Breakup by Region (in %), 2021
Figure 11: Global: Pharmacovigilance (In-house) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Pharmacovigilance (In-house) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Pharmacovigilance (Contract Outsourcing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Pharmacovigilance (Contract Outsourcing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Pharmacovigilance (Pre-clinical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Pharmacovigilance (Pre-clinical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Pharmacovigilance (Phase I) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Pharmacovigilance (Phase I) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Pharmacovigilance (Phase II) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Pharmacovigilance (Phase II) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Pharmacovigilance (Phase III) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Pharmacovigilance (Phase III) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Pharmacovigilance (Phase IV) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Pharmacovigilance (Phase IV) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Pharmacovigilance (Spontaneous Reporting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Pharmacovigilance (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Pharmacovigilance (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Pharmacovigilance (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Pharmacovigilance (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Pharmacovigilance (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Pharmacovigilance (EHR Mining) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Pharmacovigilance (EHR Mining) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Pharmacovigilance (Case Data Management) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Pharmacovigilance (Case Data Management) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Pharmacovigilance (Signal Detection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Pharmacovigilance (Signal Detection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Pharmacovigilance (Risk Management System) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Pharmacovigilance (Risk Management System) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Pharmacovigilance (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Pharmacovigilance (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Pharmacovigilance (Neurology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Pharmacovigilance (Neurology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Pharmacovigilance (Cardiology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Pharmacovigilance (Cardiology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Pharmacovigilance (Respiratory Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Pharmacovigilance (Respiratory Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Pharmacovigilance (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Pharmacovigilance (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Global: Pharmacovigilance (Pharmaceuticals Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Global: Pharmacovigilance (Pharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Global: Pharmacovigilance (Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Global: Pharmacovigilance (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Global: Pharmacovigilance (Medical Device Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Global: Pharmacovigilance (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Global: Pharmacovigilance (Other End Uses) Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Global: Pharmacovigilance (Other End Uses) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: North America: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: North America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: United States: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: United States: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Canada: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Canada: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Asia-Pacific: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Asia-Pacific: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: China: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: China: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Japan: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Japan: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: India: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: India: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: South Korea: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: South Korea: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Australia: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Australia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Indonesia: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Indonesia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Europe: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Europe: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Germany: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Germany: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: France: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: France: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: United Kingdom: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: United Kingdom: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Italy: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Italy: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Spain: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Spain: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Russia: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Russia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 96: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 97: Latin America: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 98: Latin America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 99: Brazil: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 100: Brazil: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 101: Mexico: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 102: Mexico: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 103: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 104: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 105: Middle East and Africa: Pharmacovigilance Market: Sales Value (in Million US$), 2016 & 2021
Figure 106: Middle East and Africa: Pharmacovigilance Market: Breakup by Country (in %), 2021
Figure 107: Middle East and Africa: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 108: Global: Pharmacovigilance Industry: SWOT Analysis
Figure 109: Global: Pharmacovigilance Industry: Value Chain Analysis
Figure 110: Global: Pharmacovigilance Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pharmacovigilance Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Pharmacovigilance Market Forecast: Breakup by Service Provider (in Million US$), 2022-2027
Table 3: Global: Pharmacovigilance Market Forecast: Breakup by Product Life Cycle (in Million US$), 2022-2027
Table 4: Global: Pharmacovigilance Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 5: Global: Pharmacovigilance Market Forecast: Breakup by Process Flow (in Million US$), 2022-2027
Table 6: Global: Pharmacovigilance Market Forecast: Breakup by Therapeutic Area (in Million US$), 2022-2027
Table 7: Global: Pharmacovigilance Market Forecast: Breakup by End Use (in Million US$), 2022-2027
Table 8: Global: Pharmacovigilance Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 9: Global: Pharmacovigilance Market: Competitive Structure
Table 10: Global: Pharmacovigilance Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4